The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bayer; GlaxoSmithKline; Janssen; Novartis; Pfizer
Expert Testimony - Abbvie
Real-world analysis of treatment patterns and persistence of octreotide LAR and other agents in patients with advanced gastrointestinal neuroendocrine tumors (GI NET): A multicenter study.
 
Matthew H. Kulke
Consulting or Advisory Role - Ipsen; Novartis
 
Al Bowen Benson
Consulting or Advisory Role - Advanced Accelerator Applications; Alchemia; Astellas Pharma; Bayer; Bayer/Onyx; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Celgene; DAVA Pharmaceuticals; EMD Serono; Genentech/Roche; Guardant Health; Guerbet; Helsinn Healthcare; Infinity Pharmaceuticals; IntegraGen; Lexicon; Lilly; Lilly/ImClone; Merck Serono; Novartis; Opsona Therapeutics; Pharmacyclics; Precision Therapeutics; Sanofi; Spectrum Pharmaceuticals; Taiho Pharmaceutical; TRM Oncology; Vicus Therapeutics
Research Funding - advanced accelerator applications (Inst); Alchemia (Inst); Amgen (Inst); Astellas Pharma (Inst); AVEO (Inst); Bayer/Onyx (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AVEO; Bayer; Boehringer Ingelheim; Boston Biomedical; Dava Oncology; Genentech/Roche; Gilead Sciences; Guardant Health; guerbet; Helsinn Healthcare; Lilly/ImClone; Sanofi; Spectrum Pharmaceuticals; TRM Oncology
 
A. Dasari
No Relationships to Disclose
 
Lynn Huynh
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Beilei Cai
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Research Funding - Novartis
Travel, Accommodations, Expenses - Novartis
 
Todor Totev
Research Funding - Novartis (Inst)
 
Nina Roesner
Research Funding - Novartis (Inst)
 
Mei Sheng Duh
No Relationships to Disclose
 
Maureen Neary
Employment - Novartis
 
Emily K. Bergsland
Stock and Other Ownership Interests - More Health (I)
Consulting or Advisory Role - Ipsen; Lexicon; More Health
Research Funding - Advanced Accelerator Applications (Inst); lexicon (Inst); Merck; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate